drugset / Trial / NCT06834100
Assessment of Immunogenicity, Reactogenicity and Safety of the Drug GNG-DE in Comparison With the Reference Drug
RandomizedParallel-groupSingle-blindPrevention
Summary
Assessment of immunogenicity, reactogenicity and safety of GNG-DE in comparison with the reference drug
Timeline
- Start
- 2025-02-12
- Primary completion
- 2025-12-31
- Completion
- 2025-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GNG-DE | Unknown | 0.5 ml | Intramuscular |
| Subject | Menactra | Vaccine | 0.5 ml | Intramuscular |